CD40 and neoplasm: One study demonstrated that administration of anti-CD40 Ab to tumor-bearing animals leads to maturation of DC capable of stimulating T cell activation (90), suggesting that the tumor either fails to support DC maturation or that suppression of DC maturation by the tumor is a reversible process.